Novo CEO pressed by Senate to chop costs of being overweight, diabetes medication CEO Lars Fruergaard Jørgensen told lawmakers the company would look at new talks with insurers with regards to the checklist costs of Wegovy and copyright whenever they pledge to help keep the medicines on their own formularies. https://labelthefigurewiththeitem38383.myparisblog.com/31155489/about-healthcare-news